News

Clinical features of vascular malformations and associated gene mutations

Published on: 28/11/2023

Clinical features of vascular malformations and associated gene mutations
Read the full article below
Digital Health, Thought Leadership
Member News

In the study described in the article by Diociaiuti (et al.), researchers looked at the clinical features of a number of vascular malformations (VMs) and the corresponding genetic mutations in the DNA of the affected tissue. Although the phenotypic and molecular genetic features of the majority of the patients in this study were consistent with previous literature, the researchers also observed several unusual findings.

Abstract

Sporadic vascular malformations (VMs) is a large group of disorders of the blood and lymphatic vessels caused by somatic mutations in several genes—mainly regulating the RAS/MAPK/ERK and PI3K/AKT/mTOR pathways.

The researchers performed a cross-sectional study of 43 patients affected with sporadic VMs, who had received a molecular diagnosis by high-depth targeted next-generation sequencing in their center. Clinical and imaging features were correlated with the sequence variants identified in lesional tissues. Six of nine patients with capillary malformation and overgrowth (CMO) carried the recurrent GNAQ somatic mutation p.Arg183Gln, while two had PIK3CA mutations. Unexpectedly, 8 of 11 cases of diffuse CM with overgrowth (DCMO) carried known PIK3CA mutations, and the remaining 3 had pathogenic GNA11 variants.

Recurrent PIK3CA mutations were identified in the patients with megalencephaly–CM–polymicrogyria (MCAP), CLOVES, and Klippel–Trenaunay syndrome. Interestingly, PIK3CA somatic mutations were associated with hand/foot anomalies not only in MCAP and CLOVES, but also in CMO and DCMO. Two patients with blue rubber bleb nevus syndrome carried double somatic TEK mutations, two of which were previously undescribed. In addition, a novel sporadic case of Parkes Weber syndrome (PWS) due to a RASA1 mosaic pathogenic variant was described.

Finally, a girl with a mild PWS and another diagnosed with CMO carried pathogenic KRAS somatic variants, showing the variability of phenotypic features associated with KRAS mutations. Overall, the findings of the researchers expand the clinical and molecular spectrum of sporadic VMs, and show the relevance of genetic testing for accurate diagnosis and emerging targeted therapies.

Full article

Diociaiuti A, Rotunno R, Pisaneschi E, Cesario C, Carnevale C, Condorelli AG, Rollo M, Di Cecca S, Quintarelli C, Novelli A, Zambruno G, El Hachem M. Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center Study. Biomedicines. 2022 Jun 20;10(6):1460.

Author Dr Lilian Vermeer

 

Discover more about CMTC-OVM:

CMTC-OVM is a worldwide non-profit patient organization that aims to improve the quality of life of people suffering from vascular abnormalities (blood vessel abnormalities), such as CMTC (‘Van Lohuizen syndrome’), and stimulate scientific research on these disorders.

NEWS​

Related News

Phoenix Children’s Hospital use iPads with Tough-PAC cases for Patient Engagement

24 Apr 2025
When the award-winning Phoenix Children’s Hospital decided to deploy in-room iPads as part of the trailblazing strategy to improve patient engagement,...

Patients lead the conversation: PiCC Lounge podcast brings voices to the front

24 Apr 2025
PiCC Lounge is a new podcast launched by the patient community PiCC United, giving patients a platform to share their experiences and insights into th...

ECHAlliance The Global Health Connector Champions Digital Health at World Bank Spring Meetings

22 Apr 2025

Round Table 8 – European Health Data Space (EHDS)

22 Apr 2025

Dr. Rajendra Pratap Gupta – India’s AI Healthcare Revolution

22 Apr 2025

The Collective Power of the Global Health Connector Partnership

21 Apr 2025
The Global Health Connector unites trusted partners across five continents to drive collaborative digital health innovation. Each month we will share ...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *